ALPHA MOS: management transactions · France · AMF

About ALPHA MOS

Alpha MOS is a French industrial technology company focused on sensory analysis solutions. Listed on Euronext Growth Paris under the ticker ALNEO and ISIN FR0013421286, the company designs, manufactures and markets measuring instruments that help objectify smell, taste and vision. Its core product suite is built around three flagship systems: the HERACLES electronic nose, the ASTREE electronic tongue and the IRIS electronic eye, supported by proprietary software and databases. In its official materials, Alpha MOS describes itself as a global leader in industrial sensory analyzers and states that it has installed more than 1,300 instruments worldwide, mainly across food, beverage and packaging markets. Founded in 1993 in Toulouse, Alpha MOS developed its business around the digitization of human senses for industrial quality control, R&D and process optimization. The company was the first to bring an electronic nose to market and has consistently invested in R&D to address measurement needs that were not fully covered by conventional analytical tools. Its competitive position is built on technical know-how, patents, sensor expertise and data-processing capabilities, as well as on an international footprint spanning France, China and the United States. Commercially, Alpha MOS targets manufacturers that need to standardize sensory evaluation, improve test repeatability and strengthen quality compliance. Its solutions are used to analyze odors, flavors, colors, product authenticity and packaging-related issues. The group offers a combination of instruments, software and application support, which allows it to serve both laboratory environments and selected production use cases. Its customer base includes established players in food, beverages, sports nutrition and related industrial segments. A noteworthy strategic extension is BOYDSense, Alpha MOS’ medtech subsidiary, which is developing a miniaturized breath-analysis platform for monitoring chronic diseases, initially diabetes. This initiative shows how the group is leveraging its sensory-analysis expertise beyond traditional industrial markets and into non-invasive healthcare diagnostics. Overall, Alpha MOS combines a long-standing installed base, a strong innovation culture and potential upside from applications in both industrial and medical markets.